Vaccines
With extensive experience in vaccines development, as well as market access and commercialization strategy, Quintiles is uniquely qualified to be your ally in vaccines.
Vaccines Industry Excellence Award Winner
Quintiles was named the Best Contract Research Organization in the Vaccines Industry Excellence Awards (ViE) Asia, announced during the World Vaccine Congress Asia.
Proven Track Record in Vaccines Development
With more than 20,000 talented, engaged employees in nearly 60 countries, we have provided clinical services for more than 220 vaccine trials over the past 10 years, involving more than 410,000 subjects in 67 countries worldwide. Our experience spans a broad range of infectious disease indications including seasonal and pandemic influenza, dengue fever, Japanese encephalitis, malaria, and leishmaniasis, as well as cancer vaccines. Read more about our expertise in influenza vaccines.
Preferred Provider to PDPs
Quintiles also has specialized expertise working in bioterrorism and government and non-profit funded projects. We have been recently named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs). The consortium members are funded, in part, by the Bill and Melinda Gates Foundation which has committed $10 billion over the next 10 years to help research, develop and deliver vaccines and treatments for the world’s poorest countries, with a portion of that commitment directed to the PDPs. The PDPs also receive funding from government agencies, private entities and other sources. Read more.
Learn more about our capabilities across infectious disease and other therapeutic areas.
Contact us at clinical@quintiles.com to talk about your specific needs for vaccine development. Or call toll-free: +1-866-267-4479 (in U.S.) or +800-7627-5381 (Intl).
